Recruiting NA Heart Failure NYHA Class II

Tests treatment safety and results for Heart Failure NYHA Class II

Official title Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)

ClinicalTrials.gov ID: NCT03180320

What this study is testing

What is Usual medications?

Usual medications is an investigational medicine, being studied as a potential treatment for heart failure nyha class ii.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
Chronic heart failure (CHF) is a major and growing public health problem and poses economic burden on the society. There is a need for a safe, equipment-free, low-cost, and easily implemented exercise-based cardiac rehabilitation program for CHF patients in China.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • aged 18 years or above
  • diagnosed with chronic heart failure
  • clinically stable as defined as symptoms and signs that have remained generally unchanged for at least 1 month
  • NYHA functional class II or III

You likely can't join if

  • patients who have contraindications to cardiopulmonary test
  • patients who have contraindications to exercise training
  • Patients who have serious acute or chronic organic disease or mental disorders
  • history of cardiac surgery, cardiac resynchronization therapy, or intracardiac defibrillation within the previous 3 months;
  • history of cardiac arrest within 1 year;
  • history of peripartum cardiomyopathy, hyperthyroid heart disease, primary pulmonary hypertension;
See the full eligibility criteria
Who can join
  • aged 18 years or above
  • diagnosed with chronic heart failure
  • clinically stable as defined as symptoms and signs that have remained generally unchanged for at least 1 month
  • NYHA functional class II or III
What rules you out
  • patients who have contraindications to cardiopulmonary test
  • patients who have contraindications to exercise training
  • Patients who have serious acute or chronic organic disease or mental disorders
  • history of cardiac surgery, cardiac resynchronization therapy, or intracardiac defibrillation within the previous 3 months;
  • history of cardiac arrest within 1 year;
  • history of peripartum cardiomyopathy, hyperthyroid heart disease, primary pulmonary hypertension;
  • inability to perform a bicycle stress test;
  • severe cognitive dysfunction precluding informed consent or understanding of exercise concepts;
  • current regular Baduanjin or current participation in a conventional cardiac rehabilitation program
  • current participation in another trial.

The study team makes the final eligibility decision.

Where it's taking place

  • Guangzhou, Guangdong, China

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.